Growth Hormone for the Treatment of Gastroparesis (NCT06803589)

🧪 Interventions in This Study

• Growth Hormone (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Mayo Clinic — Phoenix, Arizona
• Mayo Clinic in Arizona — Scottsdale, Arizona

📞 Contact the Study Coordinator

Phone: (480) 301-4679

Email: barahona.guillermo@mayo.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Gastroparesis

• Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve — Indianapolis, Indiana
• Vagus Nerve Response in Gastroparesis Patients — Indianapolis, Indiana
• ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve — Indianapolis, Indiana
• Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator — Dallas, Texas
• Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis — Indianapolis, Indiana
• Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial — Cleveland, Ohio

Explore by condition: All Gastroparesis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.